-
2024-510620-39-00
5
2021-04-19
Advanced RCC with clear cell component
-
2022-502600-79-00
4
2021-03-16
Endometrial cancer
-
2024-516481-11-00
5
2020-09-22
Metastatic Castration-Resistant Prostate Cancer
-
2023-506551-23-00
5
2019-11-21
Recurrent or primary advanced (Stage III or IV) endometrial cancer
-
2023-508264-29-00
5
2019-06-11
Advanced Renal Cell Carcinoma with Intermediate- or Poor-Risk Factors
-
2024-510605-28-00
5
2018-11-27
Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
-
2023-506494-35-00
5
2024-07-15
Ocular Hypertension
-
2023-509644-10-00
9
2024-06-27
Advanced Non-small Cell Lung Cancer
-
2022-502531-18-00
5
2024-01-18
Obesity
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502678-18-00
5
2023-11-07
Type 2 diabetes
-
2022-502080-38-00
5
2023-10-16
Moderate to severe rotator cuff tendinopathy
-
2022-502837-24-00
5
2023-09-25
Overweight
-
2022-501420-20-00
5
2023-05-17
Severe hypertryglyceridemia
-
2023-507569-24-00
4
2022-06-20
Myocardial Infarction, Acute
Heart Failure, Left Sided
-
2022-500881-80-00
5
2021-10-29
Chronic Heart Failure With Reduced Ejection Fraction
-
2024-513870-23-00
5
2021-06-28
Locally Advanced or Metastatic Unresectable Urothelial Cancer
-
2023-506918-45-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
-
2023-506919-18-00
5
2021-05-17
Mild cognitive impairment (MCI) or mild dementia, both of the Alzheime
-
2023-504990-19-00
5
2021-04-06
Agitation in Patients With Dementia of the Alzheimer's Type
-
2023-508443-40-00
5
2020-12-18
Lung Cancer, Non-Small Cell
-
2024-514495-41-00
5
2020-11-04
Primary Progressive Multiple Sclerosis
-
2023-506923-27-00
5
2020-10-30
Type 2 diabetes
-
2022-501972-25-00
5
2020-04-06
Locally Advanced Cervical Cancer